Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: Activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer

1. Corteś, J.
2. Fumoleau, P.
3. Bianchi, G.
4. Petrella, T.M.
5. Gelmon, K.
6. Pivot, X.
7. Verma, S.
8. Albanell, J.
9. Conte, P.
10. Lluch, A.
11. Salvagni, S.
12. Servent, V.
13. Gianni, L.
14. Scaltriti, M.
15. Ross, G.A.
16. Dixon, J.
17. Szado, T.
18. Baselga, J.